Overall rank by patents
#4,303
Across all tracked assignees
USPTO PatentsView assignee record - 83 granted patents across 30 technology areas, active 2015–2025. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: A61B (DIAGNOSIS; SURGERY; IDENTIFICATION).
The verdict
Oridion holds 83 US patents across 30 technology areas, rank #4,303 of 50,000 tracked assignees.
Oridion Medical 1987 Ltd. has been granted 83 US utility patents between 2015 and 2025, placing Oridion Medical 1987 Ltd. at rank #4,303 across all assignees tracked by PlainPatent. This portfolio spans 30 distinct Cooperative Patent Classification (CPC) subclasses, averaging 15.3 claims per patent with primary concentration in A61B (DIAGNOSIS; SURGERY; IDENTIFICATION). As a Foreign Corporation, Oridion Medical 1987 Ltd. is one of the more focused assignees in the PatentsView dataset. By volume, Oridion sits between Macdon Industries Ltd. (83 patents, rank #4,299) and The Coleman Company, Inc. (83 patents, rank #4,307) - the closest US assignees by grant volume. The composite Innovation Score of 47.2/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.
Filing cadence tells the strategic story. Between 2020 and 2025 the company received 31 grants, compared with 52 in the 2015–2019 window, a -40% shift in five-year velocity. A cooling filing rate may reflect portfolio consolidation, shifting priorities, or reduced R&D throughput. The Foreign Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.
Claim depth and technology breadth together indicate competitive posture. Oridion Medical 1987 Ltd.'s 15.3 average claims per patent sits within the typical range for solid legal coverage without excessive prosecution cost, while a multi-domain presence across 30 subclasses balances depth with breadth. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark Oridion Medical 1987 Ltd. against peers pursuing similar technology classes.
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
MacDon Industries LTD.
83 patents
NATIONAL YANG-MING UNIVERSITY
83 patents
NHN CORPORATION
83 patents
Newtonoid Technologies, L.L.C.
83 patents
Perceive Corporation
83 patents
TATSUTA ELECTRIC WIRE & CABLE CO., LTD.
83 patents
TOYOTA SHATAI KABUSHIKI KAISHA
83 patents
The Coleman Company, Inc.
83 patents
Oridion Medical 1987 Ltd.
83 patents
What this shows Oridion holds 83 patents at rank #4,303, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
By rank, the assignees closest to #4,303 in granted patent volume.
Other assignees with the most granted patents in Oridion's primary technology class.
Oridion's Innovation Score vs. every tracked assignee
Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)
47 Top 19% higher than 81% of 50,000 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2015 | 16 | 19.3% |
| 2016 | 11 | 13.3% |
| 2017 | 12 | 14.5% |
| 2018 | 7 | 8.4% |
| 2019 | 6 | 7.2% |
| 2020 | 7 | 8.4% |
| 2021 | 11 | 13.3% |
| 2022 | 5 | 6.0% |
| 2023 | 5 | 6.0% |
| 2024 | 2 | 2.4% |
| 2025 | 1 | 1.2% |
Top 15 of 30 technology areas
Overall rank by patents
#4,303
Across all tracked assignees
47.2 out of 100
How to use this portfolio
Oridion's 83 grants land it in the top 19% by Innovation Score, but volume alone doesn't tell you where the strength sits.
Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.